| Trial Name: |
Cancer Treatment Side Effects
|
| Intro: |
This research study is designed to reduce certain side effects that may be caused by a specific type of cancer treatment (Doxil). |
| Condition: |
|
| Description: |
This research study is designed to reduce certain side effects that may be caused by a specific type of cancer treatment (Doxil). The study will look at the effectiveness of vitamin B-6 (pyridoxine) for the control and/or prevention of "hand-foot syndrome", (redness, tenderness, and possibly peeling of the palms and soles) due to Doxil-related chemotherapy. The study will look at two groups of participants, one receiving daily vitamin B-6 and the other receiving a daily oral placebo (sugar pill), to see whether vitamin B-6 can reduce or prevent hand-foot syndrome. |
| Criteria: |
Participants must be treated for recurrent ovarian cancer, peritoneal cancer, fallopian tube cancer, metastatic breast cancer or advanced endometrial cancer, and must be starting Doxil chemotherapy at a starting dose of 40mg/m2 every 4 weeks. Participants must be well healed, from recent surgery, radiotherapy, or chemotherapy, with a few exceptions like for alopecia (hair loss) or neuropathy (nerve damage). Participant with reproductive potential must use an adequate contraceptive method. Participants must be able to complete questionnaires about their quality of life. |
| Contact: |
For information or to register for screening in this trial please call HealthMatch at (216) 844-5000, or complete and submit the form below. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back